Boardroom Alpha
Start trial
8-K primary document
SYK · Current Report (Form 8-K) · Filed December 4, 2025

Stryker Corp — 8-K exhibit

d78127dex991.htm
Stryker Corp on Boardroom Alpha
EX-99.1

Exhibit 99.1

 

LOGO

1941 Stryker Way

Portage, MI 49002

www.stryker.com

December 4, 2025

Press release

Stryker names Spencer Stiles President and Chief Operating Officer

Dylan Crotty promoted to Group President, Orthopaedics

PORTAGE, Mich., USA – December 4, 2025 – Stryker (NYSE:SYK), a global leader in medical technologies, announced today Spencer Stiles has been appointed President and Chief Operating Officer, effective January 1, 2026. As President and COO, Stiles will lead the company’s global businesses, strategy and mergers & acquisitions.

“Appointing Spencer President and COO role strengthens our ability to sustain high growth and leverage the breadth of our portfolio,” said Kevin Lobo, Chair and CEO. “Spencer’s deep knowledge of our business and our customers, combined with his leadership and operational execution will help position us well for the future.”

Stiles, a 27-year Stryker veteran, has served as Group President of Orthopaedics and Spine since 2019. Throughout his career, he has held leadership roles across Orthopaedics as well as MedSurg and Neurotechnology, and has overseen international regions and key supporting functions. He brings a strong track record of performance and is recognized for his strategic vision, collaborative and motivational leadership and commitment to advancing healthcare through technology.

“I’m honored to step into this role,” said Stiles, “Our customers inspire everything we do; their challenges drive our innovation, and their trust fuels our growth. Alongside our exceptional Stryker team, I’m excited for what’s next as we continue delivering meaningful impact for patients around the world.”

Dylan Crotty will be promoted to succeed Stiles as Group President, Orthopaedics. Crotty, who has spent 27 years with Stryker, currently serves as President, Instruments. During his tenure, Crotty has held roles of increasing responsibility, leading many diverse businesses including roles in Trauma & Extremities and Europe. He is a proven growth champion, known for his strong operational leadership and collaboration.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

LOGO

 

For investor inquiries:

Jason Beach, Vice President, Finance and Investor Relations

at 269-385-2600 or jason.beach@stryker.com

For media inquiries:

Kim Montagnino, Vice President, Chief Communications Officer

at 269-385-2600 or kim.montagnino@stryker.com

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer